Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 2, 2004, Pages 125-131

  Marra, Camillo ^a   Bizzarro, Alessandra ^a   Daniele, Antonio ^a   De Luca, Lara ^a   Ferraccioli, Monica ^a   Valenza, Alessandro ^a   Brahe, Christina ^a   Tiziano, Francesco Danilo ^a   Gainotti, Guido ^a   Masullo, Carlo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognitive impairment; Early and late onset

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; GENOTYPE; HETEROZYGOTE; HUMAN; INTELLIGENCE; LEARNING; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NEUROPSYCHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; AGE; AGED; ATROPHY; BRAIN; FEMALE; GENETICS; ITALY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; RISK FACTOR; STATISTICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; ROME;

EID: 4344613472     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079191     Document Type: Article

References (34)

1. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T: Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology 1995;45:2203-2206.
2. O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr: The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J Am Geriatr Soc 1998;46:1493-1498.
3. Mayeux R, Small SA, Tang M, Tycko B, Stern Y: Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiol Aging 2001;22:683-689.
4. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, Berry-Kravis E, Bach J, Fox JH, Evans DA, Bennett DA: The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002;59:1154-1160.
5. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
6. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
7. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez J, Goate A, Valdivieso F: A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 1998;18:69-71.
8. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM: Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study. Arch Neurol 1998:964-968.
9. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
10. Wahlund LO, Julin P, Lannfelt L, Lindqvist J, Svensson L: Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients. Dement Geriatr Cogn Disord 1999;10:262-268.
11. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B: Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J 1995;306:599-604.
12. Ma J, Yee A, Brewer HB Jr, Das S, Potter H: Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994;372:92-94.
13. Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM: Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 1999;96:15233-15238.
14. Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM: Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J Neurosci 2002;22:10083-10087.
15. Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD: Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995;69:757-761.
16. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA: The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 2002;73:672-677.
17. Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH: Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996;53:345-350.
18. Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Muller U: Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.
19. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
20. Riley KP, Snowdon DA, Saunders AM, Roses AD, Mortimer JA, Nanayakkara N: Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study. J Gerontol B Psychol Sci Soc Sci 2000;55:S69-S75.
21. Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL: Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-252.
22. Kim KW, Jhoo JH, Lee JH, Lee DY, Lee KU, Youn JC, Youn JY, Woo JI: The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease. Dement Geriatr Cogn Disord 2002;13:125-129.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
24. Villa G, Gainotti G, De Bonis C, Marra C: Double dissociation between temporal and spatial pattern processing in patients with frontal and parietal damage. Cortex 1990;26:399-407.
25. Mullenbach R, Lagoda PJ, Welter C: An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989;5:391.
26. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
27. Murphy GM Jr, Taylor J, Kraemer HC, Yesavage J, Tinklenberg JR: No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997;154:603-608.
28. Holmes C, Levy R, McLoughlin DM, Powell JF, Lovestone S: Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61:580-583.
29. Flory JD, Manuck SB, Ferrell RE, Ryan CM, Muldoon MF: Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet 2000;96:707-711.
30. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M: Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic lateonset Alzheimer's disease. Ann Neurol 1995;37:596-604.
31. Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, Cruts M, Van Broeckhoven C, Breteler MM, Hofman A, Stijnen T, van Duijn CM: Apolipoprotein E genotype and progression of Alzheimer's disease: The Rotterdam Study. J Neurol 1999;246:304-308.
32. Kraszpulski M, Soininen H, Helisalmi S, Alafuzoff I: The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer's disease. Acta Neurol Scand 2001;103:88-92.
33. Yip AG, Brayne C, Easton D, Rubinsztein DC: Medical Research Council Cognitive Function Ageing Study (MRC CFAS). Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J Med Genet 2002;39:639-643.
34. Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996;36:378-384.